Infusione venosa continua di buprenorfina mediante sistema elastomerico autonomo nel controllo del dolore postoperatorio.

Translated title of the contribution: Continuous venous infusion of buprenorphine with autonomous elastomeric system in the control of postoperative pain

R. Greco, M. Piastra, V. Iacovacci, F. Belcastro, E. M. Forastiere, S. Proietti, L. Piastra

Research output: Contribution to journalArticle

Abstract

We herein evaluated the analgesic effectiveness of low doses of buprenorphine with or without a primer and the practicality and usefulness of a constant flow disposable infusion set (Infusor Baxter 2 ml/h). Our series consists of 300 patients, seen between January 1992 and December 1993, randomly distributed in three groups of 100 patients each. All patients were informed before operation about the use of pain Visual Analogical Scale (VAS) and how the infusor works. At the end of the operation all patients had an infusor positioned with a 0.01 mg/kg supplied of buprenorphine diluted to 60 ml with Ringer's Lactate solution. In addition to this, group B patients received an i.v. primer of 0.003 mg/kg of buprenorphine diluted to 10 ml with saline solution and group C patients received an i.v. primer of 0.5 mg/kg of ketorolac diluted to 10 ml with saline solution. VAS, systolic arterial pressure, diastolic arterial pressure, heart rate, respiratory rate, request of analgesics and side effects were evaluated at one hour (T0), six hours (T1), 12 hours (T2), 24 hours (T3) and 36 hours (T4) after operation. Group B and C patients showed significant reduction in VAS compared to group A patients at T0 and T1 but the difference disappeared starting from T2. Group B and C patients showed blood pressure, heart rate and respiratory rate values significantly reduced compared to group A patients at T0 and T1. Such values however then stabilized. Side effects encountered were nausea and vomiting in different percentages in the three groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Original languageItalian
Pages (from-to)1-8
Number of pages8
JournalMinerva Anestesiologica
Volume60
Issue number10 Suppl 2
Publication statusPublished - Oct 1994

Fingerprint

Buprenorphine
Postoperative Pain
Infusion Pumps
Respiratory Rate
Blood Pressure
Sodium Chloride
Analgesics
Arterial Pressure
Heart Rate
elastomeric
Ketorolac
Nausea
Vomiting
Pain

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Greco, R., Piastra, M., Iacovacci, V., Belcastro, F., Forastiere, E. M., Proietti, S., & Piastra, L. (1994). Infusione venosa continua di buprenorfina mediante sistema elastomerico autonomo nel controllo del dolore postoperatorio. Minerva Anestesiologica, 60(10 Suppl 2), 1-8.

Infusione venosa continua di buprenorfina mediante sistema elastomerico autonomo nel controllo del dolore postoperatorio. / Greco, R.; Piastra, M.; Iacovacci, V.; Belcastro, F.; Forastiere, E. M.; Proietti, S.; Piastra, L.

In: Minerva Anestesiologica, Vol. 60, No. 10 Suppl 2, 10.1994, p. 1-8.

Research output: Contribution to journalArticle

Greco, R, Piastra, M, Iacovacci, V, Belcastro, F, Forastiere, EM, Proietti, S & Piastra, L 1994, 'Infusione venosa continua di buprenorfina mediante sistema elastomerico autonomo nel controllo del dolore postoperatorio.', Minerva Anestesiologica, vol. 60, no. 10 Suppl 2, pp. 1-8.
Greco, R. ; Piastra, M. ; Iacovacci, V. ; Belcastro, F. ; Forastiere, E. M. ; Proietti, S. ; Piastra, L. / Infusione venosa continua di buprenorfina mediante sistema elastomerico autonomo nel controllo del dolore postoperatorio. In: Minerva Anestesiologica. 1994 ; Vol. 60, No. 10 Suppl 2. pp. 1-8.
@article{5357a3511c154c309b6797c67db038c0,
title = "Infusione venosa continua di buprenorfina mediante sistema elastomerico autonomo nel controllo del dolore postoperatorio.",
abstract = "We herein evaluated the analgesic effectiveness of low doses of buprenorphine with or without a primer and the practicality and usefulness of a constant flow disposable infusion set (Infusor Baxter 2 ml/h). Our series consists of 300 patients, seen between January 1992 and December 1993, randomly distributed in three groups of 100 patients each. All patients were informed before operation about the use of pain Visual Analogical Scale (VAS) and how the infusor works. At the end of the operation all patients had an infusor positioned with a 0.01 mg/kg supplied of buprenorphine diluted to 60 ml with Ringer's Lactate solution. In addition to this, group B patients received an i.v. primer of 0.003 mg/kg of buprenorphine diluted to 10 ml with saline solution and group C patients received an i.v. primer of 0.5 mg/kg of ketorolac diluted to 10 ml with saline solution. VAS, systolic arterial pressure, diastolic arterial pressure, heart rate, respiratory rate, request of analgesics and side effects were evaluated at one hour (T0), six hours (T1), 12 hours (T2), 24 hours (T3) and 36 hours (T4) after operation. Group B and C patients showed significant reduction in VAS compared to group A patients at T0 and T1 but the difference disappeared starting from T2. Group B and C patients showed blood pressure, heart rate and respiratory rate values significantly reduced compared to group A patients at T0 and T1. Such values however then stabilized. Side effects encountered were nausea and vomiting in different percentages in the three groups.(ABSTRACT TRUNCATED AT 250 WORDS)",
author = "R. Greco and M. Piastra and V. Iacovacci and F. Belcastro and Forastiere, {E. M.} and S. Proietti and L. Piastra",
year = "1994",
month = "10",
language = "Italian",
volume = "60",
pages = "1--8",
journal = "Minerva Anestesiologica",
issn = "0375-9393",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "10 Suppl 2",

}

TY - JOUR

T1 - Infusione venosa continua di buprenorfina mediante sistema elastomerico autonomo nel controllo del dolore postoperatorio.

AU - Greco, R.

AU - Piastra, M.

AU - Iacovacci, V.

AU - Belcastro, F.

AU - Forastiere, E. M.

AU - Proietti, S.

AU - Piastra, L.

PY - 1994/10

Y1 - 1994/10

N2 - We herein evaluated the analgesic effectiveness of low doses of buprenorphine with or without a primer and the practicality and usefulness of a constant flow disposable infusion set (Infusor Baxter 2 ml/h). Our series consists of 300 patients, seen between January 1992 and December 1993, randomly distributed in three groups of 100 patients each. All patients were informed before operation about the use of pain Visual Analogical Scale (VAS) and how the infusor works. At the end of the operation all patients had an infusor positioned with a 0.01 mg/kg supplied of buprenorphine diluted to 60 ml with Ringer's Lactate solution. In addition to this, group B patients received an i.v. primer of 0.003 mg/kg of buprenorphine diluted to 10 ml with saline solution and group C patients received an i.v. primer of 0.5 mg/kg of ketorolac diluted to 10 ml with saline solution. VAS, systolic arterial pressure, diastolic arterial pressure, heart rate, respiratory rate, request of analgesics and side effects were evaluated at one hour (T0), six hours (T1), 12 hours (T2), 24 hours (T3) and 36 hours (T4) after operation. Group B and C patients showed significant reduction in VAS compared to group A patients at T0 and T1 but the difference disappeared starting from T2. Group B and C patients showed blood pressure, heart rate and respiratory rate values significantly reduced compared to group A patients at T0 and T1. Such values however then stabilized. Side effects encountered were nausea and vomiting in different percentages in the three groups.(ABSTRACT TRUNCATED AT 250 WORDS)

AB - We herein evaluated the analgesic effectiveness of low doses of buprenorphine with or without a primer and the practicality and usefulness of a constant flow disposable infusion set (Infusor Baxter 2 ml/h). Our series consists of 300 patients, seen between January 1992 and December 1993, randomly distributed in three groups of 100 patients each. All patients were informed before operation about the use of pain Visual Analogical Scale (VAS) and how the infusor works. At the end of the operation all patients had an infusor positioned with a 0.01 mg/kg supplied of buprenorphine diluted to 60 ml with Ringer's Lactate solution. In addition to this, group B patients received an i.v. primer of 0.003 mg/kg of buprenorphine diluted to 10 ml with saline solution and group C patients received an i.v. primer of 0.5 mg/kg of ketorolac diluted to 10 ml with saline solution. VAS, systolic arterial pressure, diastolic arterial pressure, heart rate, respiratory rate, request of analgesics and side effects were evaluated at one hour (T0), six hours (T1), 12 hours (T2), 24 hours (T3) and 36 hours (T4) after operation. Group B and C patients showed significant reduction in VAS compared to group A patients at T0 and T1 but the difference disappeared starting from T2. Group B and C patients showed blood pressure, heart rate and respiratory rate values significantly reduced compared to group A patients at T0 and T1. Such values however then stabilized. Side effects encountered were nausea and vomiting in different percentages in the three groups.(ABSTRACT TRUNCATED AT 250 WORDS)

UR - http://www.scopus.com/inward/record.url?scp=0028522755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028522755&partnerID=8YFLogxK

M3 - Articolo

C2 - 7761010

AN - SCOPUS:0028522755

VL - 60

SP - 1

EP - 8

JO - Minerva Anestesiologica

JF - Minerva Anestesiologica

SN - 0375-9393

IS - 10 Suppl 2

ER -